DIGNITANA BRINGS FDA-CLEARED DIGNICAP® SYSTEM TO THREE MORE CITIES IN THE U.S.

More American Cancer Centers Sign On to Provide Patients with an Alternative to
Chemotherapy Related Hair Loss—One of the Most Devastating Side Effects of
Chemotherapy
Lund, Sweden—April 27, 2016—Dignitana AB, a world leader in medical scalp
-cooling technology, announced today that the DigniCap® scalp cooling system,
which was recently cleared by the FDA to effectively reduce the likelihood of
chemotherapy-induced hair loss in women with breast cancer, is now also
available at three more cancer treatment centers across the U.S.

The DigniCap® system is the first and only scalp cooling device to complete
rigorous FDA clinical trials in the U.S., where seven out of ten patients with
early-stage breast cancer kept at least 50% of their hair.

Since FDA clearance in December 2015, more than fifteen U.S. medical centers
have begun the process of introducing the DigniCap® scalp cooling system to
their patients. Agreements with several others are currently in discussion and
early adopters like The Angeles Clinic and Research Institute, an affiliate of
Cedars-Sinai, are ordering additional systems as well.

To date, the DigniCap system has contracts in place at the following U.S.
medical centers: Bronson Battle Creek Cancer Care
Center (https://www.bronsonhealth.com/locations/bronson-battle-creek-cancer-care
-center/), Charleston Hematology Oncology Associates (https://www.choasc.com/),
Chesapeake Oncology and Hematology Associates (http://cohamed.org/), Florida
Cancer Specialists & Research Institute (https://www.flcancer.com/), Mount Sinai
Beth Israel Cancer Center (https://www.wehealny.org/services/cancer/), Mount
Sinai Comprehensive Cancer Center (http://msccc.com/), Orange County Blood and
Cancer Care (http://www.memorialcare.org/), The Angeles Clinic and Research
Institute (http://www.theangelesclinic.org/), an affiliate of Cedars-Sinai, The
Dubin Breast Center at The Mount Sinai
Hospital (https://www.mountsinai.org/patient-care/service-areas/cancer/cancer
-services/dubin-breast-center),Toledo Clinic Cancer
Center (http://www.toledocliniccancercenters.com/), UCSF Helen Diller Family
Comprehensive Cancer Center (http://cancer.ucsf.edu/), UT Health Science Center
San Antonio’s Cancer Therapy & Research Center (http://www.uthscsa.edu/patient
-care/ctrc), and Wake Forest Baptist Medical
Center (http://www.wakehealth.edu/).

The following cancer treatment centers are the most recent sites in the U.S. to
provide the DigniCap® scalp cooling system in their breast cancer treatment
regimens:

  · Menorah Medical Center
 (http://menorahmedicalcenter.com/service/cancer-care)Overland Park, Kansas
  · Oncology & Hematology Specialists
 (http://www.oncologyandhematology.net/)Denville, New Jersey
  · Stamford Health Bennett Cancer Center (https://www.stamfordhealth.org/care
-treatment/cancer/cancers-we
-treat/?gclid=CjwKEAjwgPe4BRCB66GG8PO69QkSJAC4EhHhbAjPU25khADPseaFC9eNQu0U9AFQ9V
Z 
EJSM0pbvejBoC2Pjw_wcB)
Stamford, Connecticut

Stamford Health Bennett Cancer Center is the first medical center in Connecticut
to sign an agreement with Dignitana in order to offer the DigniCap® system to
patients undergoing chemotherapy for breast cancer, making the scalp cooling
treatment more accessible to patients in the Northeast.

“For patients and families dealing with a cancer diagnosis, it’s important that
a center combines a high level of physician expertise, the most advanced
treatment options and a personalized approach that looks not only at the
disease, but also at the patient and his or her unique physical, emotional and
spiritual needs,” said Elizabeth Manfredo, Director of The Stamford Health
Bennett Cancer Center. “Introducing the DigniCap system will allow us to offer
our patients a way to address chemotherapy–induced alopecia – hair loss that can
have a substantial impact on the quality of life for many patients.”

The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai, was one
of the first ten medical centers in the U.S. to offer the DigniCap® scalp
cooling system to their patients. After several successful patient treatments,
they are among the first round of centers now requesting additional systems.

“We are thrilled that the DigniCap® scalp cooling system is so well-received in
the U.S. marketplace and proud to be fulfilling requests at such prestigious
cancer centers,” said Jan Richardsson, Chief Executive Officer of Dignitana.
“These three additional centers are committed to bringing better quality of life
treatment options to their cancer patients, and this alternative to avoid
chemotherapy induced hair loss allows them to do just that.”

The DigniCap® scalp cooling system features a patented tight-fitting silicone
cooling cap that is placed directly on the head, and an outer neoprene cap that
insulates and secures the silicone cap. The cooling cap is connected to a
cooling and control unit with touch screen prompts. A liquid coolant circulates
throughout the silicone cap, delivering consistent and controlled cooling to all
areas of the scalp. The cap is fitted to the head, and the temperature of the
scalp is lowered, resulting in vasoconstriction with reduced delivery of
chemotherapy to the scalp, as well as reduced cellular uptake of drugs due to
decreased intra follicular metabolic rate. These factors together reduce the
risk of chemotherapy-induced hair loss.
För mer info:

Jan Richardsson
VD, Dignitana AB (publ)

Telefon: 046-16 30 92
E-post: jan.richardsson@dignitana.se
Om Dignitana AB (publ)
Dignitanas, med säte i Lund, affärsidé är att utveckla, tillverka och
marknadsföra den medicintekniska produkten DigniCap®. Dignitana bedriver en
kontinuerlig forskning och utveckling av nya användningsområden för DigniCap®.
Dignitanas aktier handlas på NASDAQ OMX First North med Erik Penser Bank som
Certified Adviser. För mer information gå in på: www.dignitana.se

Om skalpkylningssystemet DigniCap®
Dignitanas huvudprodukt - skalpkylningssystemet DigniCap® - är ett patenterat
system med syfte att eliminera eller kraftigt reducera håravfall för patienter
som genomgår cytostatikabehandling. DigniCap® erbjuder skalpkylning med jämn
kyla, hög effektivitet, säkerhet och acceptabel komfort.